Amundi’s Ardent Health ARDT Stock Holding History

Amundi’s Portfolio ARDT Stock Details ARDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,338	Closed	-$148K	–	2187
2026 Q1	$148K	Buy	+17,338	New	+$156K	﹤0.01%	1921

Other funds holding ARDT

CTC

Chai Trust Company Chicago, Illinois $1.45B AUM 10.17% 1-Year Est. Return

Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi's ARDT Position: Q2 2026 in Review

Amundi sold out of Ardent Health (ARDT) in Q2 2026, closing a stake of 17,338 shares — an estimated $148K sold.

Amundi first reported a position in ARDT in Q1 2026 and held it in 1 quarter. The position peaked at $148K in Q1 2026. 138 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

Amundi reported no remaining Ardent Health position as of Q2 2026 after selling out during the quarter.
Amundi sold 17,338 Ardent Health shares in Q2 2026, an estimated $148K.
Amundi first reported a position in Ardent Health in Q1 2026 and held it in 1 quarter.
Amundi's Ardent Health position peaked at $148K in Q1 2026.
138 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.